Cellexus Lands Canadian Distributor | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK-based bioreactor maker Cellexus said today that it has signed up Vancouver-based life and analytical sciences company Discovery Scientific to distribute its products in Canada.

Cellexus supplies the CellMaker line of single-use disposable bioreactors for use in cell culture and fermentation bioprocesses.

Cellexus of Huntington, UK, said that the distribution agreement is part of an expansion strategy to drive up sales in key regions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.